Thyrocare Technologies Limited – NSE:THYROCARE.NS
Thyrocare Technologies Limited stock price today
Thyrocare Technologies Limited stock price monthly change
Thyrocare Technologies Limited stock price quarterly change
Thyrocare Technologies Limited stock price yearly change
Thyrocare Technologies Limited key metrics
Market Cap | 50.30B |
Enterprise value | 48.78B |
P/E | 58.92 |
EV/Sales | 7.82 |
EV/EBITDA | 28.95 |
Price/Sales | 7.87 |
Price/Book | 10.13 |
PEG ratio | -47.57 |
EPS | 13.54 |
Revenue | 5.71B |
EBITDA | 1.43B |
Income | 707.6M |
Revenue Q/Q | 13.51% |
Revenue Y/Y | 8.58% |
Profit margin | 13.47% |
Oper. margin | 17.37% |
Gross margin | 51.27% |
EBIT margin | 17.37% |
EBITDA margin | 25.13% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeThyrocare Technologies Limited stock price history
Thyrocare Technologies Limited stock forecast
Thyrocare Technologies Limited financial statements
| Jun 2023 | 1.34B | 173M | 12.83% |
|---|---|---|---|
| Sep 2023 | 1.48B | 203.3M | 13.74% |
| Dec 2023 | 1.34B | 153.5M | 11.39% |
| Mar 2024 | 1.54B | 177.8M | 11.53% |
| 2026 | 7.54B | 1.19B | 15.91% |
|---|
Analysts Price target
Financials & Ratios estimates
| Payout ratio | 0% |
|---|
| 2016 | 1.19% |
|---|---|
| 2017 | 1.05% |
| 2019 | 0.95% |
| 2020 | 6.06% |
| 2022 | 1.93% |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 5926900000 | 1.05B | 17.72% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 6438800000 | 1.16B | 18.05% |
| Jun 2023 | 196.6M | 0 | 0 |
|---|---|---|---|
| Sep 2023 | 213M | 0 | 0 |
| Dec 2023 | 269.4M | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 |
Thyrocare Technologies Limited alternative data
| Aug 2023 | 2,115 |
|---|---|
| Sep 2023 | 1,645 |
| Oct 2023 | 1,645 |
| Nov 2023 | 1,645 |
| Dec 2023 | 1,645 |
| Jan 2024 | 1,645 |
| Feb 2024 | 1,645 |
| Mar 2024 | 1,645 |
| Apr 2024 | 1,645 |
| May 2024 | 1,645 |
| Jun 2024 | 1,645 |
| Jul 2024 | 1,645 |
Thyrocare Technologies Limited other data
| Insider | Compensation |
|---|---|
Dr. Velumani Arokiaswamy Ph.D. (1959) Chief Executive Officer | $12 |
-
What's the price of Thyrocare Technologies Limited stock today?
One share of Thyrocare Technologies Limited stock can currently be purchased for approximately $1,111.9.
-
When is Thyrocare Technologies Limited's next earnings date?
Unfortunately, Thyrocare Technologies Limited's (THYROCARE.NS) next earnings date is currently unknown.
-
Does Thyrocare Technologies Limited pay dividends?
Yes, Thyrocare Technologies Limited pays dividends and its trailing 12-month yield is 1.94% with 0% payout ratio. The last Thyrocare Technologies Limited stock dividend of $0 was paid on 5 Sep 2025.
-
How much money does Thyrocare Technologies Limited make?
Thyrocare Technologies Limited has a market capitalization of 50.30B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 2.88% to 5.72B US dollars.
-
What is Thyrocare Technologies Limited's stock symbol?
Thyrocare Technologies Limited is traded on the NSE under the ticker symbol "THYROCARE.NS".
-
What is Thyrocare Technologies Limited's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Thyrocare Technologies Limited?
Shares of Thyrocare Technologies Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Thyrocare Technologies Limited's key executives?
Thyrocare Technologies Limited's management team includes the following people:
- Dr. Velumani Arokiaswamy Ph.D. Chief Executive Officer(age: 66, pay: $12)
-
How many employees does Thyrocare Technologies Limited have?
As Jul 2024, Thyrocare Technologies Limited employs 1,645 workers.
-
When Thyrocare Technologies Limited went public?
Thyrocare Technologies Limited is publicly traded company for more then 9 years since IPO on 10 May 2016.
-
What is Thyrocare Technologies Limited's official website?
The official website for Thyrocare Technologies Limited is thyrocare.com.
-
How can i contact Thyrocare Technologies Limited?
Thyrocare Technologies Limited can be reached via phone at +91 22 4125 2525.
Thyrocare Technologies Limited company profile:
Thyrocare Technologies Limited
thyrocare.comNSE
1,693
Medical - Diagnostics & Research
Healthcare
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Navi Mumbai, 400703
:
ISIN: INE594H01019
CUSIP: Y8T01E103
